SARS-CoV-2 vaccine protection and deaths among US veterans during 2021

We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine effectiveness against infection (VE-I) and death (VE-D) by vaccine type in 780,225 veterans in the Veterans Health Administration, covering 2.7% of the US population. From February to October 2021, VE-I declined for all v...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohn, Barbara A., Cirillo, Piera M., Murphy, Caitlin C., Krigbaum, Nickilou Y., Wallace, Arthur W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836205/
https://www.ncbi.nlm.nih.gov/pubmed/34735261
http://dx.doi.org/10.1126/science.abm0620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836205/
https://www.ncbi.nlm.nih.gov/pubmed/34735261
http://dx.doi.org/10.1126/science.abm0620

Ejemplares similares